Dr. Maris is co-leading a study that aims to develop patient-specific cancer vaccines that could be applied to patients in remission to prevent relapse.
Investigators in the Center for Childhood Cancer Research have received a five-year grant totaling more than $12.5 million to develop the Center for Pediatric Tumor Cell Atlas.